Navigation Links
Formedix Releases Transform for OpenClinica to Drive Efficiencies in Clinical Trials
Date:11/19/2013

Burlington, MA (PRWEB) November 19, 2013

Formedix, leading provider of clinical trial automation software and consultancy services, is delighted to announce the new product release, as a result of their partnership with OpenClinica, LLC, producers of the world’s most widely used open source electronic data capture software. The collaboration brings an integration between Formedix Origin universal clinical trial design tools and OpenClinica’s uniquely flexible open source system for Electronic Data Capture (EDC) and Clinical Data Management to the market.

The product, named Formedix Transform for OpenClinica, is now available and joins the leading range of EDC integrations offered by Formedix. Transform for OpenClinica integrates with Formedix Universal Design Tool, Origin, to merge study specification and EDC build into one process which significantly reduces OpenClinica study build times-in some cases by more than 65%. Other capabilities include study build automation and drag-and-drop reuse, enhanced by leveraging portable, vendor neutral CDISC designs.

CROs and sponsors now have even greater choice when selecting an EDC system with the introduction of Transform for OpenClinica and its diverse capabilities. Companies no longer need to struggle to meet sponsor requests or train in multiple EDC systems because, with Formedix, training only needs to be given for one study design tool.

Mark Wheeldon, CEO of Formedix, was invited to present at OC13, the 2013 OpenClinica Global Conference, earlier this year, to discuss using CDISC standards to drive efficiencies in study set-up and build with OpenClinica. He also spoke in detail about how Formedix is working with partners, such as OpenClinica, to develop cutting-edge solutions to help achieve further reductions in study build times.

Mark said, “Formedi
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. "Collaborate to Innovate" with Formedix at DIA Annual Meeting 2012
2. Formedix Partners with Perceptive Informatics for Forthcoming Webcast, “Four Secrets to Using CDISC Standards to Enable Clinical Trial Efficiencies”
3. Formedix to Host Webinar: Discover Define-XML - Practical Uses Today and a Technical Deep Dive on March 14, 2013
4. Formedix and OmniComm Partner to Offer CRO and Sponsors Multi-Vendor EDC Capabilities
5. Formedix to Host Executive Breakfast prior to Bay Area CDISC Network Meeting, May 23, 2013
6. Take a Standards Health Check with Formedix at DIA 49th Annual Meeting
7. Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston
8. Formedix Partners With OpenClinica to Deliver Automated End-to-End Clinical Trial Builds
9. HealthCare Institute of New Jersey Releases 2011 Biopharmaceutical and Medical Technology Economic Impact Data
10. HCCS Releases ICD-10 Countdown Clock With Integrated CMS Twitter Tweets
11. eCareSoft Releases eCS Cirrus™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... May 27, 2015  The Companion Diagnostics Deals ... and unprecedented access to the partnering deals and ... companies during 2014. Using these reports, ... the partnering activities of the past year. The ... partnering and alliances deals announced worldwide.The initial chapters ...
(Date:5/27/2015)... , May 27, 2015 RXi ... company focused on discovering and developing innovative therapies ... today announced that it has commenced a public offering ... purchase shares of its common stock and overallotment ... stock. The shares of common stock, warrants and ...
(Date:5/27/2015)... , May 26, 2015 ... announced the addition of Jain PharmaBiotech,s new ... and Companies" to their offering. ... molecular diagnostics technologies that will play an ... health, pharmaceutical industry, forensics and biological warfare ...
(Date:5/27/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/8nqqdw/global_breast ) ... Breast Cancer Monoclonal Antibodies Market Outlook 2020" ... seems to dominate the breast cancer monoclonal antibody ... molecule, Herceptin has been able to dominate this ... breast cancer cells become recalcitrant and relapsed condition ...
Breaking Biology Technology:Companion Diagnostics Deals and Alliances of 2014 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 2RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants 3Global Molecular Diagnostics Market 2015-2024 - Analysis of Key Technologies, Markets and Companies 2Global Molecular Diagnostics Market 2015-2024 - Analysis of Key Technologies, Markets and Companies 3Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 2Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 3
... July 27 ... optimize clinical trial enrollment for life sciences companies, is ... 100 award based on their successful deployment of DecisionView ... is a web-based patient enrollment optimization solution that automates ...
... July 27 All signs point to accelerated growth in ... explosion of demand for services, central government policy continues to urge greater ... on Wednesday, September 8 , executives and managers can learn how ... , , , ...
... July 27 Article One Partners, the world,s ... $5 million round of institutional funding with Alleghany ... SE: Y), and other investors. The funding will be used ... online patent validation sector by enhancing existing products and services, ...
Cached Biology Technology:Pfizer Wins CIO 100 Award for Patient Enrollment Optimization Solution From DecisionView 2Orchestrall Sponsors 'China Business Toolbox': Brings Focus to the 'How and When' of China Market Access 2Orchestrall Sponsors 'China Business Toolbox': Brings Focus to the 'How and When' of China Market Access 3Article One Announces Completion of Funding from Alleghany Corporation 2Article One Announces Completion of Funding from Alleghany Corporation 3
(Date:5/19/2015)... May 19, 2015 ... the addition of the  "Genetic Testing Market ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic ... analysis of the current and future genetic ... tests, their working principles and types are ...
(Date:5/14/2015)... 14, 2015  Verificient Technologies, Inc., a ... online remote proctoring, announced a new alliance ... and creator of the Canvas Learning Management ... companies will benefit from the seamless integration ... As a fully integrated multifactor biometrics behavioral ...
(Date:5/11/2015)... Curemark LLC, a privately held drug research ... Phase III double blind, randomized, placebo-controlled clinical trial to ... all children ages 3-8 with Autism. Previously, Curemark announced ... blinded clinical trial for CM-AT in children ages 3-8 ... enzyme chymotrypsin. This new trial will help determine whether ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
... largest ever to have taken place in a large ... HIV, and is the first study of this kind ... been coordinated by Javier Martínez-Picado, ICREA research professor in ... and Josep M. Miró, consultant of the Unit of ...
... binds to a neuron, how does the cell know to ... with other questions involving good sensations, the answer appears to ... appearing with a commentary in Nature Neuroscience online proposes a ... in the cell membrane and brings news of nicotine’s arrival. ...
... wild squash. The length of the day relative to ... induction of flowering in many plant species. Short day (SD) ... long night) in order to flower. These are plants that ... fall in temperate regions. Long day (LD) plants will flower ...
Cached Biology News:Identified main genetic variants involved in response to HIV 2Nicotine rush hinges on sugar in neurons 2Research identifies protein that signals flowering in squash plants 2Research identifies protein that signals flowering in squash plants 3
Human VEGF R3/Flt-4 Phycoerythrin MAb (Clone 54733)...
Immunogen: Synthetic Peptide: V(22) N G H E F E I E G E G E G R(36) Storage: -20 C, Avoid Freeze/Thaw Cycles...
Human beta IG-H3 MAb (Clone 348506) Keywords: BIGH3, betaIG-H3 Protein Family: Extracellular Matrix Molecules...
Human Siglec-9 Biotinylated Affinity Purified Pab...
Biology Products: